首页|表观遗传修饰调控哮喘发生的研究进展

表观遗传修饰调控哮喘发生的研究进展

扫码查看
哮喘是由多种细胞以及细胞组分介导的慢性气道炎症性疾病.其发病率较高、发病时间长且病情反复发作,不容易治愈,已严重影响人们的身体健康.哮喘的发病机制复杂,迄今仍未阐明.近年来,作为一种调控基因变化的方式,表观遗传修饰介导的基因调控过程与哮喘发病的复杂病理生理变化过程密切相关,是最近被认为影响哮喘发病和异质性的重要机制之一.因此,本文将通过表观遗传修饰的三种主要方式:DNA甲基化、组蛋白修饰和microRNA的异常表达来介绍其在调控哮喘发生中的研究进展,以期为进一步研究哮喘的表观遗传修饰调控机制提供新的思路,以及发现新的哮喘生物标记物和治疗靶点提供参考.
Research progress of epigenetic modification regulating asthma occurrence
Asthma is a kind of heterogeneous chronic airway inflammation involving multiple cells.It has seriously threatened human health and life because of the high incidence,recurrent illness and a long course of the disease.Its pathogenesis is complex and has not yet been elucidated.In recent years,epigenetics,as a mechanism of regulating gene changes through epigenetic modification,by which mediated the gene regulation process is closely related to the complex pathophysiological changes of asthma,and is one of the mechanisms affecting the pathogenesis and heterogeneity of asthma.Therefore,this paper reviews advanced research progress in the regulation of asthma through three main ways of epigenetic modification—DNA methylation,histone modification,and the mechanism progress of microRNA in the occurrence and development of asthma,in order to clarify a new epigenetic regulation mechanism of asthma,and provide clues for the discovery of new asthma biomarker and a new therapeutic target for the treatment of asthma.

epigeneticsasthmaDNA methylationhistone modificationmicroRNA

卢佩珊、李佳宁、欧阳岁东

展开 >

广东医科大学广东省医学分子诊断重点实验室,东莞 523808

广东医科大学医学技术学院,东莞 523808

东莞市寮步医院,东莞 523430

表观遗传 哮喘 DNA甲基化 组蛋白修饰 microRNA

广东省自然科学基金面上项目广东医科大学"两校结对合作科研团队"项目广东省中医药局面上项目广东省基础与应用基础研究基金联合项目

2021A15150110454SG22261G202214122022A1515140075

2023

生命的化学
中国生物化学与分子生物学会

生命的化学

CSTPCD
影响因子:0.404
ISSN:1000-1336
年,卷(期):2023.43(8)
  • 72